Quantcast

Latest Cord blood Stories

2014-09-18 12:30:29

DUBLIN, Sept. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Stem Cell Industry Report, 2014-2017" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological...

2014-09-15 23:09:12

ChinaMarketResearchReports.com adds Latest Report on “Global and China Stem Cell Industry Report, 2014-2017” to its store. Inquire before buying on this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114908 Dallas, TX (PRWEB) September 15, 2014 Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment...

2014-09-10 16:26:28

SAN BRUNO, Calif., Sept. 10, 2014 /PRNewswire/ -- September is designated as National Childhood Cancer Awareness Month. The federal health observance provides an opportunity to heighten awareness of the formidable public health challenges presented by childhood cancer. According to the National Cancer Institute, cancer is the leading cause of death by disease in children and adolescents ages 1 to 19 years old in the United States. Pediatric patients with blood cancers have diseased...

2014-09-05 08:23:18

HONG KONG, Sept. 5, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company's Compensation Committee (the "Committee") has approved an allocation of 5,840,000 restricted share units ("RSUs") to be issued to selected members (the "Potential Participants") of the CCBC management team....

2014-09-02 16:22:29

NEW YORK, Sept. 2, 2014 /PRNewswire-USNewswire/ -- The cover story of the September 2014 edition of Chemical and Engineering News, titled "Aiming for HIV's Weak Spot," cites work by NYBC's Asim Debnath, Ph.D., and his Laboratory of Molecular Modeling and Drug Design for their work to identify small molecules that prevent HIV from entering T cells. Here's a link to the story: http://cen.acs.org/articles/92/i35/Aiming-HIVs-Weak-Spot.html Dr. Debnath's lab was the first to discover the...

2014-08-25 08:27:08

HONG KONG, Aug. 25, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has been informed that Magnum Opus International Holdings Limited ("Magnum"), a private vehicle that is controlled by CCBC Chairman Mr. Yuen KAM and involves the CCBC management team, together with Cordlife...

2014-08-22 23:05:03

Cryo-Cell International, Inc., the world’s first cord blood bank, announced today that it has provided funding to complete an Investigational New Drug Application (IND) for a FDA approved Phase I clinical trial for patients that have amyotrophic lateral sclerosis (ALS or Lou Gehrig's) disease using umbilical cord blood cells. Oldsmar, FL (PRWEB) August 22, 2014 This funding was made through an additional investment in Cryo-Cell’s cell therapy research affiliate, Saneron CCEL...

2014-08-21 08:28:14

Earnings Call Scheduled for 8:00 a.m. ET on August 29, 2014 HONG KONG, Aug. 21, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the first quarter of fiscal year 2015 on Thursday, August 28, 2014, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Friday, August 29, 2014 to discuss its financial performance and give a brief overview of the Company's recent...

2014-08-21 04:21:13

WASHINGTON, NEW YORK and LONDON, Aug. 21, 2014 /PRNewswire-USNewswire/ -- As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years. http://photos.prnewswire.com/prnvar/20140801/132627 BioInformant's latest report, "Complete 2013-14 U.S. Cord Blood Banking Industry Report," explores...

2014-08-19 04:22:39

JERUSALEM, August 19, 2014 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com ], a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG [http://www.novartis.com ] ("Novartis"). According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell. The option is exercisable...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.